Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Berobenatide, the investigational product in the VESPER program, was specifically designed to be cost-efficient to manufacture with efficacy equivalent to best-in-class options and better tolerability, said John B
But people who have insurance coverage for it may pay as little as $25 for a one or three-month prescription
About the authors Dr
Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about orforglipron as a potential treatment for adults with type 2 diabetes, and the timeline for future readouts, presentations, and other milestones relating to orforglipron and its clinical trials and reflects Lilly's current beliefs and expectations
US$ 22.93
US$ 21.23
US$ 25.29
